Skip to main content

ADVERTISEMENT

Mark Reisman, MD

08/01/2008
Vascular brachytherapy, the delivery of a single dose of a radioactive isotope directly inside the target area of the coronary artery after balloon angioplasty, is the only clinically proven therapy and is the standard of care for patients...
Vascular brachytherapy, the delivery of a single dose of a radioactive isotope directly inside the target area of the coronary artery after balloon angioplasty, is the only clinically proven therapy and is the standard of care for patients...
Vascular brachytherapy, the...
08/01/2008
Journal of Invasive Cardiology
Original Contribution
01/06/2009
For Percutaneous Coronary Interventions in the Clinical Outcomes Assessment Program ABSTRACT: Published mortality models for percutaneous coronary intervention (PCI), including the Clinical Outcomes Assessment Program (COAP) model, have not...
For Percutaneous Coronary Interventions in the Clinical Outcomes Assessment Program ABSTRACT: Published mortality models for percutaneous coronary intervention (PCI), including the Clinical Outcomes Assessment Program (COAP) model, have not...
For Percutaneous Coronary...
01/06/2009
Journal of Invasive Cardiology
06/02/2014
The inability to reposition or retrieve balloon-expandable transcatheter aortic valves once they have been deployed requires implantation of the valve in the descending aorta or open surgical procedures to extract the valve. We describe the...
The inability to reposition or retrieve balloon-expandable transcatheter aortic valves once they have been deployed requires implantation of the valve in the descending aorta or open surgical procedures to extract the valve. We describe the...
The inability to reposition or...
06/02/2014
Journal of Invasive Cardiology
06/14/2019
Journal of Invasive Cardiology
Original Contribution
10/23/2017
Prosthetic leaflet thrombosis is a growing concern in transcatheter aortic valve replacement (TAVR). We analyzed patients undergoing native-valve TAVR between 2012 and 2015 based on anticoagulant use at hospital discharge.
Prosthetic leaflet thrombosis is a growing concern in transcatheter aortic valve replacement (TAVR). We analyzed patients undergoing native-valve TAVR between 2012 and 2015 based on anticoagulant use at hospital discharge.
Prosthetic leaflet thrombosis is...
10/23/2017
Journal of Invasive Cardiology